ArticleJournal of contemporary brachytherapy2022
High-dose-rate brachytherapy (interventional radiotherapy) in lip carcinoma with rigid needles: a simple technique with excellent results.
Article in Journal of contemporary brachytherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lip carcinoma has been treated for years with low-dose-rate (LDR) brachytherapy, achieving local control greater than 90%. Comparison between LDR and high-dose-rate (HDR) showed that they are equivalently efficient in local control, but HDR results in fewer complications. Interstitial implant of rigid needles or plastic tubes (interventional radiotherapy) is the current standard. Lip carcinomas are usually exophytic, and rigid parallel needles allow for a better dose distribution with more homogeneity, by adding needles placed outside the tissue to cover protruding lesions. Treatment is administered in 5 days, B.I.D. 4.5-5 Gy × 9 fractions. This pictorial essay illustrates the technique of implanting rigid needles in post-operative cases of early and advanced carcinomas of the lip. This technique is straightforward to learn, and is practical and safe with appropriate training. It should be considered in selected patients with lip carcinoma as the first therapeutic option. Departments with HDR brachytherapy units and experienced in interventional radiotherapy should be offering such treatment, as it greatly benefits patients with lip cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.